Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrokine 3, pseudogene (GKN3P) is part of the gastrokine family, which in other mammals includes proteins (such as GKN1, GKN2, and GKN3) involved in gastric mucosal health and defense. In humans, the GKN3 locus contains a premature stop codon and splice site mutations, rendering it an inactive pseudogene with no verified protein product or function. Unlike functional gastrokines, GKN3P is not expressed or detectable at the protein level in human tissues and is not implicated as a molecular target in disease or therapy. However, its mouse and pig orthologs are functional and may play roles in stomach cell maintenance and metaplasia, hinting at evolutionary changes uniquely affecting the human lineage.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrokine 3, pseudogene (GKN3P).